Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CompuMed Inc. (CMPD : OTC)

• Company Description    COMPUMED, INC. is a medical systems company engaged primarily in the application of computer technology to medicine. The main aspects of Co.'s business are (i) the licensing of its proprietary technology in the OsteoGramR, a bone density test that was developed by the Company as a means of aiding physicians in diagnosing and monitoring osteoporosis, (ii) the computer interpretation of electrocardiograms, (iii) TeleCor Services Division, which is engaged in transtelephonic cardiac event monitoring. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $6.60 Daily Weekly Monthly 20 Day Moving Average: 611 shares Shares Outstanding: 1.33 (millions) Market Capitalization: $8.78 (millions) Beta: -0.53 52 Week High: $6.95 52 Week Low: $1.95 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 11.86% 5.01% 12 Week 35.38% 23.84% Year To Date 49.74% 36.65%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5777 West Century Blvd. Suite 360 - Los Angeles,CA 90045 USA ph: 310-258-5000 fax: 310-645-5880 investorrelations@compumedinc.com http://www.compumedinc.com

• General Corporate Information    Officers Lee Keddie - Chief Executive Officer and President David W. Pointer - Chairman Laura Carroll - Chief Financial Officer and Corporate Secretary Loren Den Herder - Director Charles Gillman - Director Peer Information CompuMed Inc. (BJCT) CompuMed Inc. (CADMQ) CompuMed Inc. (APNO) CompuMed Inc. (UPDC) CompuMed Inc. (IMTIQ) CompuMed Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 204914501 SIC: 7374 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/12/26 Share - Related Items Shares Outstanding: 1.33 Most Recent Split Date: 5.00 (0.04:1) Beta: -0.53 Market Capitalization: $8.78 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.82 Price/Cash Flow: 12.09 Price / Sales: 1.08 EPS Growth vs. Year Ago Period: -250.00% vs. Previous Quarter: -400.00% Sales Growth vs. Year Ago Period: 8.78% vs. Previous Quarter: -3.24% ROE 03/31/26 - -6.25 12/31/25 - -1.88 09/30/25 - -1.94 ROA 03/31/26 - -3.97 12/31/25 - -1.21 09/30/25 - -1.29 Current Ratio 03/31/26 - - 12/31/25 - - 09/30/25 - 2.04 Quick Ratio 03/31/26 - - 12/31/25 - - 09/30/25 - 2.01 Operating Margin 03/31/26 - -2.51 12/31/25 - -0.78 09/30/25 - -0.85 Net Margin 03/31/26 - -2.51 12/31/25 - -0.78 09/30/25 - -0.85 Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - -0.57 Book Value 03/31/26 - - 12/31/25 - - 09/30/25 - 2.34 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - 24.31 Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - 0.16 Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - 13.58

Powered by Zacks Investment Research ©